文献速递母胎医学产科

Ⅰ期双胎输血综合征激光手术的结局

Outcomes of laser surgery for stage I twin-twin transfusion syndrome.
PubMed 文献 · Prenat Diagn · 2022-01-20

本研究为单中心回顾性研究,纳入2006至2019年孕16至26周接受激光手术的Ⅰ期双胎输血综合征单绒毛膜双羊膜囊双胎,主要结局为6月龄存活率。114例中至少一胎存活者占97.4%,双胎存活占88.6%,严重神经病学并发症占2.7%(6/220),结论认为在有经验的胎儿手术中心激光手术是合理选择,需进一步研究优化治疗策略。

要点

  • 单中心激光队列6月龄至少一胎存活97.4%,双胎存活88.6%。
  • 严重神经病学并发症2.7%(6/220),无严重神经病学并发症的6月龄存活为90.0%。
  • 作者认为在有经验的胎儿手术中心激光手术是Ⅰ期双胎输血综合征的合理治疗选择。

核心结论

  • 鉴于良好的存活率和神经病学结局,在有经验的胎儿手术中心激光手术是Ⅰ期双胎输血综合征的合理治疗选择。
  • 需进一步研究以优化治疗策略。

研究设计与样本

  • 回顾性研究,纳入2006至2019年孕16至26周接受激光手术的Ⅰ期双胎输血综合征单绒毛膜双羊膜囊双胎。
  • 126例连续Ⅰ期双胎输血综合征患者中114例(90.5%)符合纳入标准。
  • 主要结局为6月龄存活率,同时评估完整存活,次要结局与随机对照试验的期待治疗组进行比较。

主要发现

  • 分娩孕周中位数(范围)为34.1(20.6-39.4)周。
  • 6月龄时单中心激光队列至少一胎存活比例为97.4%,双胎存活为88.6%。
  • 110例妊娠(220例胎儿)有神经病学并发症结局,严重神经病学并发症发生率为2.7%(6/220),无严重神经病学并发症的6月龄存活为90.0%。
  • 结局与随机对照试验期待治疗组相比更有利。

临床怎么用

  • 作者认为在有经验的胎儿手术中心激光手术是Ⅰ期双胎输血综合征的合理治疗选择。
  • 作者提出需进一步研究以优化治疗策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: A recent randomized controlled trial (RCT) demonstrated no difference in 6 month survival in expectantly managed stage I twin-twin transfusion syndrome (TTTS) patients and those undergoing immediate laser surgery. We aimed to describe outcomes following immediate laser surgery at a single fetal surgery center. METHODS: A retrospective study of monochorionic diamniotic twins diagnosed with stage I TTTS who underwent laser surgery between 16 and 26 gestational weeks from 2006 to 2019. The primary outcome was 6 month survivorship. Intact survival was also assessed. Secondarily, outcomes were compared to the RCT expectant management group. RESULTS: Of 126 consecutive stage I TTTS patients, 114 (90.5%) met inclusion criteria. Median (range) gestational age at delivery was 34.1 (20.6-39.4) weeks. At 6 months, the proportion of patients with at-least-one survivor in the single-center-laser cohort was 97.4%, with 88.6% dual survivorship. Neurological morbidity outcomes were available in 110 pregnancies (220 fetuses). Severe neurological morbidity occurred in 2.7% (6/220), and 6 month survival without severe neurological morbidity was 90.0%. Outcomes compared favorably with the RCT expectant management group. CONCLUSIONS: Given favorable survival and neurological outcomes, laser surgery is a reasonable treatment option for stage I TTTS at experienced fetal surgery centers. Further study is warranted to optimize treatment strategies.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Gomez NG, Monson MA, Chon AH, et al. Outcomes of laser surgery for stage I twin-twin transfusion syndrome. Prenat Diagn. 2022. PMID: 35032038. doi:10.1002/pd.6094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。